IA
DNA icon

IFP Advisors’s Ginkgo Bioworks DNA Stock Holding History

IFP Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17K Buy
421
+378
+879% +$3.16K ﹤0.01% 3890
2026
Q1 		$264 Buy
+43
New +$358 ﹤0.01% 4565
2025
Q4 		– Sell
-27
Closed -$394 – 4920
2025
Q3 		$394 Buy
27
+1
+4% +$12 ﹤0.01% 4245
2025
Q2 		$293 Buy
26
+12
+86% +$93 ﹤0.01% 4559
2025
Q1 		$80 Hold
14
– – ﹤0.01% 3921
2024
Q4 		$137 Sell
14
-575
-98% -$4.93K ﹤0.01% 3913
2024
Q3 		$249 Buy
589
+572
+3,365% +$5.73K ﹤0.01% 3199
2024
Q2 		$226 Sell
17
-8
-32% -$239 ﹤0.01% 3140
2024
Q1 		$1.15K Hold
25
– – ﹤0.01% 2836
2023
Q4 		$1.67K Buy
25
+3
+14% +$184 ﹤0.01% 2715
2023
Q3 		$1.62K Hold
22
– – ﹤0.01% 2888
2023
Q2 		$1.63K Buy
22
+8
+57% +$474 ﹤0.01% 2942
2023
Q1 		$7K Sell
14
-2,006
-99% -$127K ﹤0.01% 2430
2022
Q4 		$985K Sell
2,020
-12
-0.6% -$1.1K 0.03% 626
2022
Q3 		$991K Buy
2,032
+370
+22% +$44.1K 0.03% 641
2022
Q2 		$810K Hold
1,662
– – 0.03% 648
2022
Q1 		$810K Buy
1,662
+1,639
+7,126% +$319K 0.03% 648
2021
Q4 		$7K Hold
23
– – ﹤0.01% 2340
2021
Q3 		$10K Buy
+23
New +$11.2K ﹤0.01% 2264

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

IFP Advisors's DNA Position: Q2 2026 in Review

IFP Advisors increased its Ginkgo Bioworks (DNA) stake by 879% in Q2 2026, buying an estimated $3.16K and bringing the position to 421 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #3890.

IFP Advisors first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $991K in Q3 2022. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • IFP Advisors held 421 shares of Ginkgo Bioworks worth $4.17K as of Q2 2026.
  • IFP Advisors bought 378 Ginkgo Bioworks shares in Q2 2026, an estimated $3.16K.
  • Ginkgo Bioworks made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3890 holding.
  • IFP Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
  • IFP Advisors's Ginkgo Bioworks position peaked at $991K in Q3 2022.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.